Background: the development of specialised nutritional support techniques allows the maintenance of an adequate supply of nutrients in those patients in whom oral feeding is not possible or is insufficient in relation to their requirements, trying to improve the quality of life, especially in those with chronic diseases. Methods: single-center clinical study carried out in a clinical-nutritional center consisting of a medically supervised nasogastric-duodenal tube feeding treatment for overweight, obesity and increased body fat percentage in patients requiring it by means of duodeno-enteral feeding, expecting losses of more than 10 %. Results: twenty-nine patients completed the protocol (20.4 % male and 79.6 % female) with a mean age of 38 years (SD: 12.4); 87.2 kg (SD: 18.5) mean weight; 37.9 kg (SD: 4.8) mean iFat%; 32.4 (SD: 5.4) iMean body mass index (BMI); 100 cm (SD: 16.0) iMean waist; 113.6 cm (SD: 10.4) iMean hip; 33.8 cm (SD: 3.9) iMean upper arm circumference; 65.5 cm (SD: 7.5) iMean thigh circumference; 9.7 (SD: 4.8) iVisceral fat index; and 22.9 days (SD: 13.9) mean treatment. A mean of 22.9 (SD: 13.9) days of MESUDEFT influences weight loss, fat loss, visceral fat loss and decreased arm, hip and thigh circumferences (p < 0.05) (i: initial). Conclusions: MESUDEFT is shown to be an effective alternative as a sole treatment or as an adjunct prior to bariatric surgery for obesity or overweight treatment with a minimum of 10 % loss of BMI and fat mass at completion and 3-6 months follow-up.(AU)
Antecedentes: el desarrollo de técnicas especializadas de soporte nutricional permite mantener un aporte adecuado de nutrientes en aquellos pacientes en los que la alimentación oral no es posible o es insuficiente en relación a sus requerimientos, intentando mejorar la calidad de vida, especialmente de aquellos con enfermedades crónicas. Métodos: estudio clínico unicéntrico prospectivo realizado en un centro clínico-nutricional consistente en un tratamiento con alimentación por sonda nasogástrica-duodenal médicamente supervisado para el sobrepeso, la obesidad y el aumento del porcentaje de grasa corporal en pacientes que lo requieran mediante alimentación duodenoenteral, durante un mes aproximado, con previsión de pérdidas superiores al 10 % y con control posterior entre los tres y los seis meses siguientes. Resultados: veintinueve pacientes completaron el protocolo (20,4 % varones y 79,6 % mujeres) con una edad media de 38 años (DE: 12,4); 87,2 kg (DE: 18,5) iPeso medio; 37,9 kg (DE: 4,8) iGrasa% media; 32,4 (DE: 5,4) iIMC medio; 100 cm (DE: 16,0) iCintura media; 113,6 cm (DE: 10,4) iCadera media; 33,8 cm (DE: 3,9) iCircunferencia braquial media; 65,5 cm (DE: 7,5) circunferencia muslo media; 9,7 (DE: 4,8) iíndice de grasa visceral; y 22,9 días (DE: 13,9) de tratamiento medio. Una media de 22,9 (DE: 13,9) días de MESUDEFT influye en la pérdida de peso, la pérdida de grasa, la pérdida de grasa visceral y la disminución de las circunferencias del brazo, la cadera y el muslo (p < 0,05) (i: inicial). Conclusiones: MESUDEFT se muestra como una alternativa eficaz como tratamiento único o como coadyuvante previo a la cirugía bariátrica de la obesidad o tratamiento del sobrepeso con una pérdida mínima del 10 % del índice de masa corporal (IMC) y de la masa grasa al finalizar y con control durante los siguientes 3-6 meses.(AU)
Humans , Male , Female , Adult , Enteral Nutrition , Obesity , Overweight , Intubation, Gastrointestinal , Body Fat Distribution , Prospective Studies , Nutritional Sciences
BACKGROUND: the development of specialised nutritional support techniques allows the maintenance of an adequate supply of nutrients in those patients in whom oral feeding is not possible or is insufficient in relation to their requirements, trying to improve the quality of life, especially in those with chronic diseases. METHODS: single-center clinical study carried out in a clinical-nutritional center consisting of a medically supervised nasogastric-duodenal tube feeding treatment for overweight, obesity and increased body fat percentage in patients requiring it by means of duodeno-enteral feeding, expecting losses of more than 10 %. RESULTS: twenty-nine patients completed the protocol (20.4 % male and 79.6 % female) with a mean age of 38 years (SD: 12.4); 87.2 kg (SD: 18.5) mean weight; 37.9 kg (SD: 4.8) mean iFat%; 32.4 (SD: 5.4) iMean body mass index (BMI); 100 cm (SD: 16.0) iMean waist; 113.6 cm (SD: 10.4) iMean hip; 33.8 cm (SD: 3.9) iMean upper arm circumference; 65.5 cm (SD: 7.5) iMean thigh circumference; 9.7 (SD: 4.8) iVisceral fat index; and 22.9 days (SD: 13.9) mean treatment. A mean of 22.9 (SD: 13.9) days of MESUDEFT influences weight loss, fat loss, visceral fat loss and decreased arm, hip and thigh circumferences (p < 0.05) (i: initial). CONCLUSIONS: MESUDEFT is shown to be an effective alternative as a sole treatment or as an adjunct prior to bariatric surgery for obesity or overweight treatment with a minimum of 10 % loss of BMI and fat mass at completion and 3-6 months follow-up.
Due to the increasing prevalence of obesity and its negative consequences worldwide on public health, body composition analysis is a central pillar to assess the nutritional status. Scientists could use datasets to develop a new body fat measurement formula. Using bioelectrical impedance analysis, we analyzed the total body composition of 345 patients (234 men and 111 women) aged between 18 and 60 years residing in the metropolitan area of Barranquilla, Colombia. They have the potential for predictive formula analysis enhancing the cooperation among scientists. Due to the obesity pandemic, new datasets from other populations are needed to develop a body fat basic mathematical equation formula that could be used worldwide to determine the prevalence of overweight and obesity in a specific population group predisposed to develop metabolic syndrome or death, secondary to high cardiovascular risk.
This paper presents data collected through a questionnaire for the estimation of body dysmorphic disorder known as vigorexy, weight level and levels of exercise dependence in individuals from Barranquilla, Colombia who attend local gyms, based on their physical activity, food supplements eating habits, psychological pressure, and risk of muscle dysmorphia. The Data contains 8 tributes and 200 records; labelling obesity range according to WHO into normal, overweight or obesity. All data was collected in person and directly from users. This data can be used to generate scientific research and intelligent computational tools to identify the obesity level and muscle dysmorphia risk of an individual and to build recommender systems that monitor health and mental status.
Objective: to relate the morbidities of patients belonging to the COPD program of a health institution in Anserma, Caldas (Colombia). Material and Methods: a descriptive study was presented with a sample of 51 patients who underwent exploratory spirometry, the findings were contrasted with the main commodities reported by the patients or the Medical Record through descriptive and inferential statistics. Results: 50% of the evaluated population had at least one recorded comorbidity; the main morbidity found was Arterial Hypertension followed by Chronic Kidney Disease; an associated behavior was found between the GOLD classification and the presence of symptoms with non-statistically significant values; no statistically significant association was found between comorbidities and spirometric values. Conclusions: new research is needed that clearly values causality in the Colombian population.
OBJETIVO: relacionar las morbilidades de los pacientes pertenecientes al programa de EPOC de una institución de salud del municipio de Anserma, Caldas (Colombia). MATERIAL Y MÉTODOS: estudio descriptivo de 51 pacientes a quienes les fueron tomadas espirometrías exploratorias, los hallazgos fueron contrastados con las principales comorbilidades registradas en la Historia Clínica a través de estadística descriptiva e inferencial. RESULTADOS: 50% presentaron al menos una comorbilidad registrada, principalmente la Hipertensión Arterial seguida de la Enfermedad Renal Crónica, se encontró un comportamiento asociado entre la clasificación GOLD y la presencia de síntomas con valores no estadísticamente significativos; no se encontró asociación estadísticamente significativa entre las comorbilidades y los valores espirométricos. CONCLUSIONES: se hacen necesarias nuevas investigaciones que valoren de forma clara la causalidad en la población colombiana.
Pulmonary Disease, Chronic Obstructive/epidemiology , Adult , Asthma/epidemiology , Cerebrovascular Disorders/epidemiology , Colombia/epidemiology , Comorbidity , Coronary Disease/epidemiology , Cross-Sectional Studies , Diabetes Mellitus/epidemiology , Dyslipidemias/epidemiology , Female , Humans , Hypertension/epidemiology , Hypothyroidism/epidemiology , Male , Morbidity , Prospective Studies , Pulmonary Disease, Chronic Obstructive/physiopathology , Renal Insufficiency, Chronic/epidemiology
PURPOSE OF REVIEW: Stevia rebaudiana Bertoni is a perennial shrub with zero calorie content that has been increasing in popularity for its potential use as an adjuvant in the treatment of obesity. The level of evidence supporting general benefits to human health is insufficient. We conducted a review of the literature summarizing the current knowledge and role in human disease. RECENT FINDINGS: Despite stevia's minimal systemic absorption, studies have been promising regarding its potential benefits against inflammation, carcinogenesis, atherosclerosis glucose control, and hypertension. On the other hand, the growing popularity of artificial sweeteners does not correlate with improved trends in obesity. An increased intake of artificial non-caloric sweeteners may not be associated with decreased intake of traditional sugar-sweetened beverages and foods. The effects of Stevia on weight change have been linked to bacteria in the intestinal microbiome, mainly by affecting Clostridium and Bacteroides sp. POPULATIONS: A growing body of evidence indicates that Stevia rebaudiana Bertoni is protective against malignant conversion by inhibition of DNA replication in human cancer cell growth in vitro. Consumption of Stevia has demonstrated to be generally safe in most reports. Further clinical studies are warranted to determine if regular consumption brings sustained benefits for human health.
Objective. The objective of this study is to evaluate the effectiveness of telenutrition versus traditional nutritional consultations for female obese patients in need of nutritional treatment. Methods. A comparative clinical study was conducted among 233 obese or overweight women (including 20 who dropped out and 60 who failed) who consulted a nutrition clinic in Barranquilla (Colombia) for nutritional assessment and chose either telenutrition or a traditional consultation that included a weekly follow-up consultation over 16 weeks, food consumption patterns, Body Mass Index (BMI, kg/m(2)) registeration and waist and hip circumference registeration. Treatment responses and differences between telenutrition and the traditional consultations were made according to BMI, waist, hip and initial-waist/height ratio (iWaist), calculating for the relative risk. Results. In 68 (29.2%) women who chose traditional attention, 9 (37.5%) dropped out, 24 (40%) failed and 35 (23.5%) were successful, showing 1.4% (1.0 SD) BMI loss, 5.8% (3.4 SD) in waist circumference, 4.5% (2.8 SD) in hip circumference and 0.04% (0.02 SD) in iWaist/height ratio. In 165 (70.8%) women who chose telenutrition, 15 (62.5%) dropped out, 36 (60%) failed and 114 (76.5%) were successful, showing 1.1% (1.0 SD) BMI loss, 5.0% (3.2 SD) in waist circumference, 3.5% (3.1 SD) in hip circumference and 0.03% (0.02 SD) in iWaist/height ratio. A significance level of p < 0.05 is considered. Conclusion. Telenutrition has a failure or dropout risk factor of about half of the value of traditional consultation, and showed slight, statistically significant differences. This study concludes that telenutrition can support or sometimes replace traditional consultations when developing weight loss programs for obese women.
Objective: To evaluate if there is a relation between age groups, menarche, menstrual cycles and previous pregnancies with the success of weight loss in obese patients at a nutrition clinic. Methods: A clinical intervention study was conducted among overweight and obese patients who consulted a nutrition clinic in Barranquilla (Colombia) for the purpose of nutritional assessment. They were subject toa personalized weekly follow-up consultation over the course of 16 weeks in which food consumption patterns, anthropometric measures, body image and self-perception were registered. Results: A total of 135 patients were evaluated. 41 (30,4%) of whom did not complete the study. 69,6% patients did lose weight and 83,7% did lose waist. These losses are lower in older ages (95,5% at <18y vs. 56,4% in ≥ 45y, p=0,0085), not varying between overweight and obesity. There are significant losses in the final BMI (2,2(1,5SD) kg/m2 in <18years group vs. 1,1(0,7SD) kg/ m2 in >45years group; p=0,009), weight loss percentage (7,3(4,3SD)% vs. 3,8(2,1SD)%, p=0,013), waist loss percentage (8,8(4,1SD)% vs. 5,8(2.5SD)%, p=0,005) and hip loss percentage (5,4(3,8SD)% vs. 3,5(2,6SD)%, p=0,040). Age influence is confirmed by multivariate analysis with no considerable differences observed in relation to menarche, menstrual cycle regularity and previous pregnancy in success distribution. Influence of initial BMI is ≥5% among obese women, with an OR=3,9 (1,2 to 12,8, 95% CI) (p=0,026). Conclusion: Based on these results, age groups and initial BMI are regarded as influential factors in the successful outcome of treatment in overweight and obese patients (AU)
Objetivo: Evaluar si existe una relación entre los grupos de edad, la menarquia, ciclos menstruales y embarazos previos con el éxito en la pérdida de peso en pacientes obesos en una clínica de nutrición. Métodos: Se ha llevado a cabo un estudio entre pacientes con sobrepeso y obesidad que acudieron a una clínica de nutrición en la ciudad de Barranquilla (Colombia) con el fin de recibir un tratamiento nutricional. A todos los pacientes se les realizó un tratamiento nutricional semanal personalizado por 16 semanas continuas en los que se registraron los patrones de consumo de alimentos, medidas antropométricas, la imagen corporal y la auto-percepción. Resultados: Se evaluaron un total de 135 pacientes. 41 (30,4%) de los cuales no completaron el estudio. 69,6% perdieron peso y 83,7% perdieron cintura. Estas pérdidas son menores en edades más avanzadas (95,5% <18a vs 56,4% en ≥45a, p=0,0085), no existiendo variación entre el sobrepeso y la obesidad. Hay pérdidas significativas en el IMC final (2,2(1,5DS)kg/m2 en el grupo <18 años vs 1,1(0,7DS) kg/m2 en el grupo >45 años, p=0,009), en el porcentaje de pérdida de peso (7,3%(4,3DS) vs 3,8% (2,1DS), p=0,013), en el porcentaje de pérdida de cintura (8,8%(4,1DS) vs 5,8%(2,5DS), p=0,005) y en el porcentaje de pérdida de cadera (5,4%(3,8DS) vs 3,5%(2,6DS), p=0,040). La Influencia de la edad es confirmada por el análisis multivariante, no apreciándose diferencias considerables en relación con la menarquia, la regularidad del ciclo menstrual y embarazo previos en la distribución de éxito. La influencia del IMC inicial es ≥5% entre las mujeres obesas, con un de OR=3,9 (1,2 a 12,8, IC del 95%) (p=0,026). Conclusión: Basados en los resultados, los grupos de edad y el IMC inicial son considerados como factores influyentes en el éxito del tratamiento en pacientes con sobrepeso y obesidad (AU)
Humans , Female , Adolescent , Young Adult , Menarche/physiology , Menstrual Cycle/physiology , Overweight/therapy , Obesity/therapy , Body Image , Body Mass Index , Nutrition Assessment , Nutritional Status , Treatment Outcome , Colombia/epidemiology , Age Factors
Objetivo: Evaluar la respuesta al tratamiento según sexo en una consulta de nutrición por sobrepeso y obesidad. Métodos: Se realiza un estudio clínico entre pacientes de un centro médico nutricional en tratamiento estético de sobrepeso y obesidad, realizado mediante valoración y tratamiento médico nutricional por seguimiento continuo semanal y personalizado durante 16 semanas, basado en su consumo habitual de alimentos, adecuación de la cantidad de alimentos y percepción de su estado de salud y bajada de peso. Resultados: De la muestra inicial de 271 pacientes que acudieron a consulta para bajar de peso y mejorar su imagen corporal (233♀/ 38♂) se excluyeron a 100 pacientes (98♀ y 2♂) por encontrase en normopeso (IMC<25) (test Chi2 p<0.001, OR=0,08; IC 95% 0,01-0,32 de únicamente razones de estética de los hombres frente a las mujeres). De los 171 pacientes con sobrepeso u obesidad, siguieron el tratamiento 155 (122♀ y 33♂), con un 68,4% de éxito en la pérdida de peso y cintura, no encontrándose diferencias estadísticas entre sexos. La pérdida de peso en los pacientes que han seguido el tratamiento es mayor en hombres que en mujeres (6,2% (4,2DE) frente a 4,6% (3,8DE), p=0,026); observándose un mayor descenso de IMC en hombres que en mujeres (2,0 kg/m2(1,5DE) frente a 1,4kg/m2(1,1DE) p=0,009); y mayor porcentaje en pérdida cintura (8,1%(4,6DE) frente a 6,2%(3,8DE), p=0,018); no siendo significativa la diferencia de porcentaje de pérdida cadera. En el análisis de correlación logística multinomial se ha encontrado que el único factor condicionante significativamente (p<0,001) en el éxito de pérdida de peso es de forma inversa la edad; es decir, que hay más fracasos a mayor edad, no teniendo influencia ni el grupo de IMC ni el sexo. Conclusión: La asistencia por razones de estética corporal a la consulta de tratamiento de sobrepeso u obesidad es mayor en mujeres que en hombres, siendo la adherencia al tratamiento igual en ambos sexos. Sin embargo, los hombres obtienen mayores pérdidas que las mujeres. La edad condiciona de forma inversa el éxito en el tratamiento
Objective: To evaluate the genre treatment results at a nutrition clinic for overweight and obesity. Methods: A clinical study was conducted among overweight and obese patients who consulted a nutrition clinic for the purpose of nutritional assessment, subject to a personalized weekly follow-up consultation over the course of 16 weeks in which food consumption patterns, body image and weight decreasing. Results: Women attend more than men (233 versus38); a total of 271 patients were evaluated, discarding98 women and 2 men because normal weight (Chi2 testp<0.001, OR=0.08, 95%CI 0.01 to 0.32 for aesthetic reasons by gender). 171 patients followed the treatment,155 (122 women and 33 men), with a 68.4 %success in weight and waist loss and with no statistical difference between genders. Weight loss in patients who have followed the treatment is higher in men than in women (6.2% (4.2SD) versus 4.6% (3.8SD),p=0.026); greater BMI decrease in men than in women(2.0kg/m2 (1.4SD) versus 1.0kg/m2 (1.1SD) p=0.009);and higher waist loss percentage (8.1% (4.6SD) versus6.2% (3.8SD), p=0.018); being no significant difference in hip loss percentage. By multinomial logistic analysis correlation the only determining significantly factor (p<0.001) in weight loss success is inversely age; so there are more older age failures with no BMI group or gender influence. Conclusion: Based on these results, women attend more for aesthetic reasons than men, with equal treatment adherence in both sexes. However, men get higher losses than women. Age conditions inversely treatment success (AU)
Humans , Overweight/therapy , Obesity/therapy , Diet, Reducing , Self Concept , Evaluation of Results of Therapeutic Interventions , Patient Compliance , Nutritional Support/methods , Age and Sex Distribution
Objective. To explore anthropometric changes in normal-weight, overweight and obese subjects who did not dropout or fail a weight loss program over the 16 treatment weeks to improve patient motivation and treatment adherence. Methods. A clinical intervention study was conducted among 271 (including 100 dropouts and/or failures) obese and overweight patients who consulted a nutrition clinic in Barranquilla (Colombia) for the purpose of nutritional assessment. They were subject to a personalized weekly follow-up consultation over the course of 16 weeks in which initial and the final Body Mass Index (BMI, kg/m(2)), photographs, food consumption patterns, percentage weight loss, waist and hip circumference were registered and grouped according to BMI, measuring treatment response. Data's nonparametric statistical comparison was made. Results. In 62 patients from the BMI < 25 group, there is weight loss of 2.6% (3.1 SD), 5.5% (3.3 SD) in waist circumference and 3.0% (2.5 SD) in hip circumference. In 67 patients from the 25 ≥ BMI < 30 group, there is weight loss of 3.8% (4.1 SD), 5.7% (4.5 SD) in waist circumference loss and 3.7% (3.0 SD) in hip circumference loss. In 42 patients from the BMI > 30 group, there is weight loss of 4.8% (3.7 SD), 7.0% (3.6 SD) in waist circumference loss and 3.9% (2.4 SD) in hip circumference loss. Monitoring is done every 4 weeks by the Friedman test, with significant differences between the three groups (p < 0.001). Patients do not drop out of treatment because they start to see physical results in waist decrease. When comparing final values of initial waist/hip circumference ratios and waist/height ratios, a clear decrease in the three BMI groups was observed (p < 0.001). Conclusion. After three weeks of continuous treatment patients improved in all overweight and obesity parameter indicators; there were not statistically significant differences in hip circumference (HC) and waist loss (WC) (%) among the three BMI groups (normal-weight, overweight, and obesity). In contrast, there were statistically significant differences in weight loss (%) and waist-to-hip ratios. Based on anthropometric outcomes and patient perception of their body image it can be concluded that the waist circumference loss is the parameter that retains obese patients in the weight loss program.
OBJECTIVE: To evaluate if there is a relation between age groups, menarche, menstrual cycles and previous pregnancies with the success of weight loss in obese patients at a nutrition clinic. METHODS: A clinical intervention study was conducted among overweight and obese patients who consulted a nutrition clinic in Barranquilla (Colombia) for the purpose of nutritional assessment. They were subject to a personalized weekly follow-up consultation over the course of 16 weeks in which food consumption patterns, anthropometric measures, body image and self-perception were registered. RESULTS: A total of 135 patients were evaluated. 41 (30,4%) of whom did not complete the study. 69,6% patients did lose weight and 83,7% did lose waist. These losses are lower in older ages (95,5% at.
Objetivo: Evaluar si existe una relacion entre los grupos de edad, la menarquia, ciclos menstruales y embarazos previos con el exito en la perdida de peso en pacientes obesos en una clinica de nutricion. Métodos: Se ha llevado a cabo un estudio entre pacientes con sobrepeso y obesidad que acudieron a una clinica de nutricion en la ciudad de Barranquilla (Colombia) con el fin de recibir un tratamiento nutricional. A todos los pacientes se les realizo un tratamiento nutricional semanal personalizado por 16 semanas continuas en los que se registraron los patrones de consumo de alimentos, medidas antropometricas, la imagen corporal y la auto-percepcion. Resultados: Se evaluaron un total de 135 pacientes. 41 (30,4%) de los cuales no completaron el estudio. 69,6% perdieron peso y 83,7% perdieron cintura. Estas perdidas son menores en edades mas avanzadas (95,5%
Menarche/physiology , Menstrual Cycle/physiology , Overweight/therapy , Adolescent , Age Factors , Body Image , Body Mass Index , Female , Humans , Nutrition Assessment , Nutritional Status , Obesity/therapy , Treatment Outcome , Young Adult
